secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2023-02-15T23:59:59+00:00
Accession:  0001213900-23-012084
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma files provisional patent for CNS-homing peptides to treat Alzheimer's
--------------------------------------------------------------------------------

- Filed provisional patent for CNS-homing peptides targeting Alzheimer's disease and dementia.
- Peptides designed to reduce toxicity and improve therapeutic payload delivery to affected cells.
- CEO Eric Weisblum cited unmet need for effective Alzheimer's treatments and targeted delivery approach.
- Silo Pharma continues preclinical studies of novel therapeutics including psychedelic research.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023012084/0001213900-23-012084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023012084/ea173740-8k_silopharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-012084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer